Advertisement

Reactions Weekly

, Volume 1714, Issue 1, pp 64–64 | Cite as

Azacitidine

De novo acute myeloid leukaemia: case report
Case report
  • 7 Downloads

Reference

  1. Ruggiu M, et al. Azacytidine in combination with tyrosine kinase inhibitors induced durable responses in patients with advanced phase chronic myelogenous leukemia. Leukemia and Lymphoma 59: 1659-1665, No. 7, 3 Jul 2018. Available from: URL: http://doi.org/10.1080/10428194.2017.1397666 - FranceCrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations